baber/WOPTO huggingface dataset:
Patent EP-0285204-A1 (EP)
Inventor: MONTALI SERGIO
IPC: B65H59/36
Filed: 1988-03-17
Abstract: A device and method for winding conical bobbins (24) with yarn withdrawn at constant speed from individual spinning units, and comprising: a lever system with two arms (2, 4) and having the ability to move with swing motion about an axis by means of a bush (3) positioned as a rigid element joining together said arms, of which one (4) operates as a yarn storage and return element and, at the same time, as a tension compensator and regulator element for the yarn being wound, and the other (2) operates as a linear position element of a system for controlling and monitoring the effective yarn storage during the entire bobbin formation cycle; analog or digital transducers (7, 17) which convert the positions of the yarn storage element (4, 5) into a series of electrical signals; an electrical comparator (8) which compares said electrical signals with reference signals corresponding to regular storage in order to generate a control signal when a signal arises which is outside the range of regular storage values; an electronic control unit (8) which converts said control signal into a signal which activates the operation of a drive source (9); a drive source which, under the influence of said control signal,   increases or decreases the preloading of the spiral elastic element (6) in order to adjust the tension of the yarn being wound; a bidirectional drive unit (50) which, activated by the persistence of non-regular storage swing, inclines the axis of the conical bobbin (24) to displace the diameter of effective contact between the bobbin and drive roller (22), to consequently obtain a variation in the average yarn winding speed in order to restore the storage swing to within the range of values corresponding to regular storage.
Patent EP-0306078-A1 (EP)
Inventor: SHAW HENRY
IPC: D03C7/08
Filed: 1988-08-23
Abstract: A selvedge maker has a rotating pivoting body, two thread guides with pivoting connections to the body at one end pivoting about axes at an angle to their own axes and at an angle to the body, a guide for the thread guides, and a drive for the body.
Patent EP-0331829-A1 (EP)
Inventor: KILLAT GEORGE R
IPC: C08F8/32
Filed: 1988-03-10
Abstract: Chelation resins are formed by attaching a Michaels addition adduct of ammonia, a primary amine, an alkylene diamine or a polyalkylene polyamine and at least one mole of an alkyl or inertly substituted alkyl ester of an a,B-ethylenically unsaturated carboxylic acid per mole of amine hydrogen to a water-insoluble organic polymer, said polymer having a plurality of reactive groups that react with a nitrogen atom of the Michaels addition adduct to attach the adduct thereto through said nitrogen atom; and converting at least one of the ester groups on said Michaels adduct to an acid group.
Patent EP-0299698-A1 (EP)
Inventor: KURIHARA KOZO
IPC: A61L33/00
Filed: 1988-07-11
Abstract: A composition comprising a polymer having dispersed therethrough a prostacyclin derivative of formula (I):
      (in which R¹ represents hydrogen or lower alkyl, R² represents a C₃ - C₁₂ alkyl group or a C₃ - C₁₂ alkenyl group; and  n  is an integer from 1 to 5) and pharmaceutically acceptable salts thereof can be used to make a medical appliance from which the prostaglandin, having antithrombotic properties, will be released gradually and in a controlled way.
Patent EP-0307106-A1 (EP)
Inventor: UMENO MASAYUKI
IPC: C07C43/23
Filed: 1988-08-23
Abstract: The compound is prepared by reacting a p- or m-tert-­butoxyphenyl halide in which hydroxyl group of p- or m-tert-­halogenophenol is protected by a tert-butyl group with metallic magnesium to produce a p- or m-tert-­butoxyphenylmagnesium halide and reacting the same with ethylene oxide. 
     The tert-butyl group which is a hydroxy-protective group in the compound is easily eliminated by treatment under mild acid conditions but is inactive to metallic reagents such as Grignard reagents and organic lithium compound or inorganic alkalis. Therefore, the tert-butyl protective group can selectively be eliminated by converting the present compound with the above-cited reagents to a variety of ether or ester compounds and treating the product under mild acid conditions without damaging the ether or ester bond. The compound can also be converted to p- or m-butoxystyrene monomer by subjecting the former to dehydration reaction. The monomer can be polymerized followed by treatment with a weak acid to eliminate the butyl group. 
     The compound is therefore useful as an intermediate for the synthesis of pharmaceuticals, agrochemicals and polymers.
Patent EP-0320167-A1 (EP)
Inventor: PACE CHARLES HENRY
IPC: F16D66/02
Filed: 1988-11-30
Abstract: The assembly has a friction element including a back plate (1) and a lining (2) of friction material. A probe (3) of a wear indicator device is passed through a slot (4) in the back plate (1) which is dimensioned to permit passage of a part (6A) of the probe (3) when the major axes of said part (6A) and the slot (4) are aligned. Reverse movement of the probe (3) through the slot (4) is prevented by a surface of the back plate (1) after rotation of the probe (3) from its aligned position, the part (6A) then resting in recesses (9). A protective sheath (8) for an electrical lead (7) of the wear indicator provides resilient force to hold the probe (3) in its assembled condition.
Patent EP-0307292-A1 (EP)
Inventor: CHARLOT YVES
IPC: H01M50/77
Filed: 1988-09-02
Abstract: A device according to the invention is placed on board a marine craft (1). It comprises an electrochemical unit (3) of Ag-Al or Ag-Li type, and a reservoir (5), which are separated by a partition (6). During storage, the reservoir (5) contains a pulverulent alkaline product (4). A looped circuit allows the liquid electrolyte to be circulated between the electrochemical unit (3) and the reservoir (5). This circuit comprises a circulating pump (9), a hydrogen separator (13) and a pipe (7) which permanently and freely communicates with the sea throughout circulation of the electrolyte. The reservoir and the electrochemical unit are separated by a partition (6) and are interconnected by two pipes (16, 22) which traverse this partition and which each comprise a tearable membrane (20, 23) which isolates the reservoir from the electrochemical unit during storage and which is torn when the liquid electrolyte begins to circulate. One application is the construction of electrical propulsion units for marine craft. <IMAGE>
Patent EP-0299887-A1 (EP)
Inventor: JUGE ANDRE
IPC: G01R27/02
Filed: 1988-07-06
Abstract: The test appliance detects the occurrence of various conduction effects in the layers concerned and separates surface effects from corner and perimeter effects in the two perpendicular directions in which the test patterns of predetermined shapes are inserted in the elementary components comprising the said polarized layers in the direction of their thickness. The structure consists of at least four test patterns (11, 13, 15, 17) in which the said layers are defined by four rectangles, each of which is derived from the others through a common dimension, i.e. the four rectangles have only two length dimensions (YD) and two width dimensions (XD). 
<IMAGE>
Patent EP-0283466-A1 (EP)
Inventor: HODL SIEGFRIED G
IPC: E05G7/00
Filed: 1988-03-10
Abstract: In a protection device for counters, such as, for example, post office, railway station or bank counters, with a guard shield moved vertically in guides and with a drive (4), the guard shield is designed as an armour-plated roller blind (5) and, in the rolled-up position, is arranged underneath the aperture of the counter. Preferably, at the same time, the drive (4) of the armour-plated roller blind (5) is arranged underneath the aperture of the counter, preferably directly on the roller blind shaft (3). Such a design affords a space-saving and simple construction of a protection device, by means of which rapid closing becomes possible. <IMAGE>
Patent EP-0292536-A1 (EP)
Inventor: ALLEN DAVID WILLIAM
IPC: B65D81/22
Filed: 1987-12-09
Abstract: Ce dispositif de nettoyage et de conservation des pinceaux utilisés pour la peinture se présente sous la forme d'un sachet (1) fermé hermétiquement qui contient une certaine quantité d'un liquide (3) destiné à conserver ou nettoyer les pinceaux, que l'on peut ouvrir en découpant l'un de ses bords ou en tirant sur une bande pour le déchirer, afin de permettre l'introduction immédiate, après usage, de l'extrémité (5, 6) du pinceau, soit, pour en empêcher le durcissement, afin que l'instrument puisse être immédiatement utilisé, soit pour le nettoyer. Le sachet est confectionné de préférence avec une feuille de matière souple pouvant s'enrouler (7) autour du manche (4), pour assurer l'étanchéité.
Patent EP-0348431-A1 (EP)
Title: Liposome-incorporated nystatin.
Inventor: LOPEZ-BERESTEIN GABRIEL
IPC: A61K9/50
Filed: 1988-03-02
Abstract: The present invention involves a liposomal agent for treating disseminated fungal infection in an animal. This liposomal agent comprises the polyene antifungal compound nystatin. The nystatin is encapsulated within a liposome. The liposome in which the nystatin is incorporated is preferably a stable multilamellar vesicle. The liposome broadly comprises one or more lipids one or more of phosphomonoglyceride, phosphatidic acid and sphingolipid. The lipids are preferably one or more of phosphatidylcholine, phosphatidylserine, phosphatidylglycerol, sphingomyelin or phosphatidic acid. The lipids are most preferably one or more of dimyristoylphosphatidylcholine, dimyristoylphosphatidylglycerol, phosphatidylcholine and phosphatidylglycerol. The liposome of the present invention may comprise a sterol most preferably cholesterol. An important aspect of the present invention involves a method for treating disseminated fungal infection in an animal. This method comprises administering to an animal subject to disseminated fungal infection a fungicidally effective amount of nystatin encapsulated within a liposome. The liposome is composed as described above. The administering is preferably parenteral in most instances but may be oral or topical if specific colonies of fungus are thereby more directly reached. This treatment method is most useful when the animal is a human suffering from disseminated fungal infection. The method of treatment involves a fungicidally effective amount of liposome-incorporated nystatin of between about 1 mg nystatin/kg body weight and about 6 mg nystatin/kg body weight. In a most preferred embodiment the treatment method comprises liposomes consisting essentially of dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol in a ratio of about 7:3.
Patent EP-0344215-A1 (EP)
Title: Systeme de communication optique sans fil
Inventor: FASEN KENNETH
IPC: H04B10/118
Filed: 1988-03-21
Abstract: Le système de communication optique sans fil de courte portée est adapté pour être utilisé comme un système intercom. Le système peut être utilisé dans des établissements de restauration rapide et dans des centres commerciaux similaires. Le système de communication (Fig. 4) comprend une station ou poste de base (12) pour interconnecter optiquement un groupe d'unités à distance sensiblement similaires et physiquement espacées (14, 16). Chacune des unités à distance comprend un émetteur optique (33, 37) pour transmettre un faisceau optique porteur d'un message à la station de base, et un récepteur optique (35, 39) pour recevoir un faisceau optique porteur d'un message provenant de la station de base. La station de base comprend un récepteur (30) pour recevoir le faisceau optique transmis par les émetteurs optiques de toutes les unités à distance, et un émetteur optique (28) pour relayer le faisceau optique reçu et le transmettre aux récepteurs optiques de toutes les unités à distance. La station de base comprend un agencement d'horloge pour synchroniser le fonctionnement du système dans un agencement à multiplexage temporel, en établissant des tranches de temps individuelles pour la transmission des signaux depuis les unités à distance vers l'unité de base, et pour la transmission des signaux depuis l'unité de base vers les unités à distance.
Patent EP-0358718-A1 (EP)
Title: Delivery of beneficial microorganisms to seeds and plants.
Inventor: FAHEY JED W
IPC: C12N1/00
Filed: 1988-05-17
Abstract: A seed containing beneficial microorganisms, which, upon germination gives rise to a plant colonized by the microorganisms, and a method for producing the seed are provided. The seed is produced by adding the microorganisms to a biologically compatible liquid carrier to form a suspension of the microorganisms in the carrier, impregnating the seeds with the suspension, and removing the excess carrier from the seeds, whereby the viability of the microorganisms and the seeds is maintained. Plants colonized by beneficial microorganisms and methods of producing such plants are also disclosed.
Patent EP-0386121-A1 (EP)
Title: Improved zone melt recrystallization apparatus.
Inventor: ZAVRACKY PAUL M
IPC: H01L21/324
Filed: 1988-11-10
Abstract: The improved zone-melt recrystallization apparatus is comprised of a port system for providing a thermal barrier between the recrystallization chamber and the loader assembly. A bellows system is used to lift a plurality of pins that support a silicon wafer being recrystallized. Flexure supports are designed to constrain the motion of the pins within the desired direction of motion of the wafer.
Patent EP-0356671-A1 (EP)
Inventor: JACOB HANNES
IPC: F23Q2/34
Filed: 1989-07-12
Abstract: Die Haltevorrichtung umfasst ein mit einem Aufhängeorgan (11, 12) versehenes Gehäuse (10). In diesem befindet sich eine durch Haspelrolle und Rückholfeder gebildete Auszugeinrichtung für eine mit der Haspelrolle verbundene Zugleine (20). Letztere ist durch eine Gehäuseöffnung (16) geführt und dient zum Anbinden des Feuerzeugs (1). Die Gehäuseöffnung ist von einem Fangschacht (13) für das Feuerzeug (1) umgeben.
Patent EP-0355421-A1 (EP)
Inventor: DASSETTO ALESSANDRO
IPC: F02P5/15
Filed: 1989-07-21
Abstract: An electronic ignition system particularly for a two-cylinder engine (1), comprising a electronic control centre (10) including a central processor unit (11) receiving information signals (20, 25) from sensor means (21) which measure the engine rotational speed and the timing of at least one top dead centre of the engine, and sensor means (26) for measuring the pressure in the intake manifold (2) and providing a signal (25) at two levels depending on a pressure threshold value, the central unit (11) determining on the basis of said information signals (20, 25) the ignition advance angle and the moment at which to effect ignition with respect to the top dead centre, and causing the consequent activation of ignition means (15).
Patent EP-0339768-A1 (EP)
Inventor: IFE ROBERT JOHN
IPC: C07D215/48
Filed: 1989-02-23
Abstract: Compounds of structure (I):
      in which R¹ is hydrogen, C₁₋₆alkyl, C₁₋₆alkoxy, C₁₋₆alkoxy-­C₁₋₆-alkyl, C₃₋₆cycloalkyl, C₃₋₆cycloalkylC₁₋₆alkyl, phenyl, phenylC₁₋₆alkyl, the phenyl groups being optionally substituted; R² is hydrogen, C₁₋₆alkyl, C₁₋₆alkoxy, amino C₁₋₆alkylthio, halogen, cyano, hydroxy, carbamoyl, carboxy, C₁₋₆alkanoyl or trifluoromethyl; m is 1 to 3; p is 0 to 4; R³ is COR⁴; R⁴ is hydroxy, C₁₋₆alkoxy or NR⁵R⁶; R⁵ and R⁶ are each hydrogen or C₁₋₆alkyl or together with the nitrogen atom to which they are attached form a heterocyclic ring; and R⁷ is hydrogen, hydroxy, C₁₋₆alkoxy or C₁₋₆alkyl, processes for preparing them, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy as inhibitors for gastric acid secretions.
Patent EP-0357479-A1 (EP)
Inventor: JOZEFONVICZ NEE DORGEBRAY JACQ
IPC: B01J20/26
Filed: 1989-07-28
Abstract: This granular material consists of a granular porous support carrying negative or positive charges and coated on its surface with a first impregnating layer of a hydrophilic polymer carrying charges which are opposite to those of the support, the quantity of the said charges present on the said polymer being substantially equal to that of the charges present at the surface of the support; and another layer, attached to the first by irreversible chemical coupling, of another hydrophilic polymer which is functional, namely carrying functional groups imparting to the said functional hydrophilic polymer a specific but reversible affinity for at least one biological substance. Among the applications of this material are mentioned the separation and the purification of antithrombin III and of the coagulation factors (factors II, VII, VIII, IX, X) and the separation of the activated factors from the coagulation (activated II, activated IX and activated X factors) from solutions containing the said nonactivated factors.
Patent EP-0348320-A1 (EP)
Inventor: CHOQUET BRUNO
IPC: H04N7/46
Filed: 1989-06-22
Abstract: The field of the invention is that of the analysis and coding of electronic image sequences. The objective is to furnish such a process which determines the speed of displacement of the contour, in an image, and especially contours with translational displacement, intended to be inserted in an image-segmentation process allowing a compression of the image signal without psychovisual degradation of the reconstructed image. This objective is in particular achieved with the aid of a process of image segmentation into blocks with single speed of displacement vector, characterised in that it comprises a process (13) for detecting a contour in each of the said image blocks, and in that the said speed-representing vector allocated (17) to a block possessing a single predominant contour is the speed of displacement vector of the said contour. Advantageously, the speed representing vector is chosen from a set of n vectors, previously chosen (15) as being the most representative of the current image. A preferential application is to be found in TVHD image compression for transmission through MAC channel. <IMAGE>
Patent EP-0356484-A1 (EP)
Title: Process for preparation of aloe products.
Inventor: MCANALLEY BILL H
IPC: C07H15/244
Filed: 1989-01-12
Abstract: A process is described for extracting a pharmaceutically active polysaccharidic substance from the aloe plant. The pharmaceutically active polysaccharidic substance and its characteristic properties are described.
Patent EP-0363498-A1 (EP)
Inventor: INABA YOSHIHARU
IPC: G05B19/409
Filed: 1989-03-28
Abstract: The present invention provides a molding condition recorder for an injection molding machine capable of speedily determining the optimum molding conditions for producing excellent articles. The molding condition recorder is provided with a manual data input device with a CRT display having various kinds of operating keys for inputting various kinds of parameters in various kinds of parameter group for controlling the injection, dwelling, weighing and cylinder temperature and defective molding-displaying data. A microprocessor for use in a programmable machine controller has input parameters and the defective molding-displaying data stored in a molding condition memory of a common memory (S5) and the molding conditions stored in the above described manner are discriminated from molding conditions, which have been registered in a molding condition/defective molding memory file of a memory other than the common memory in similarity (S7). When both molding conditions are similar to each other, the CRT display displays an alarm message together with the parameter values and defective molding-displaying data registered in said file (S12). And, when both molding conditions are not similar, the microprocessor transfers the molding conditions stored in the common memory to the file to be stored in the file (S16). In addition, in the case where the operator judges the necessity even though the alarm message has been displayed (S13), a similar transferring and storing action is carried out.
Patent EP-0402415-A1 (EP)
Inventor: CERCEK BORIS
IPC: C07K19/00
Filed: 1989-03-01
Abstract: Le test SCM (structure de matrice cytoplasmique) est un moyen permettant de distinguer des lymphocytes isolés chez des donneurs mammifères, y compris l'homme, souffrant du cancer, des lymphocytes isolés chez des donneurs exempts de malignité. Ledit test consiste à mettre les lymphocytes en contact avec un agent d'épreuve puis à observer une diminution dans la structure de la matrice cytoplasmique chez des lymphocytes provenant de donneurs atteints du cancer; les lymphocytes provenant de donneurs non atteints du cancer ne présentent pas de diminution de structure. On quantifie de préférence la diminution de structure en mesurant la polarisation de fluorescence pour un fluor extrinsèque ajouté aux cellules, et en observant une diminution de polarisation de fluorescence après que les lymphocytes provenant d'un donneur atteint du cancer aient été mis en contact avec un agent d'épreuve. Parmi les agents d'épreuve utiles dans le test SCM se trouvent plusieurs peptides synthétiques qui sont le sujet de la présente invention. Ces peptides, dont deux ont les séquences d'amino acide Phe-Trp-Gly-Ala-Gly-Gln-Arg (I) et Phe-Trp-Gly-Ala-Glu-Gly-Gln-Arg (II), réagissent avec des lymphocytes provenant de donneurs ayant n'importe quel type de malignité. Parmi les aspects de cette invention on trouve également quelques autres peptides dont on s'attend à ce qu'ils aient une activité SCM du fait de leur relation structurelle proche des peptides I et II, des procédés d'utilisation des peptides synthétiques SCM-actifs dans des tests visant à déterminer la présence ou l'absence de malignité, des anticorps liant spécifiquement les peptides synthétiques, y compris des anticorps monoclonaux, ainsi que des sondes génétiques composées de séquences d'ADN correspondant aux séquences d'amino acides des peptides synthétiques SCM-actifs.
Patent EP-0402418-A1 (EP)
Inventor: STEVENS ERICH LABORATORY OF CL
IPC: A61K39/35
Filed: 1989-04-22
Abstract: A liquid allergen composition of biological origin obtained by extraction at a pH value of between 5.5 and 6.5, which, as additive comprises a compound of the formula <CHEM> in which X and Y are independently hydrogen or C1 - C5 alkyl group, M is an alkylene or cycloalkylene group, A is a substituted or unsubstituted methylene group and n is equal to 0 or 1 or a pharmaceutically compatible salt of this compound. The allergenic compositions are storable at the extraction pH-values.
Patent EP-0368992-A1 (EP)
Title: Actions of hormones.
Inventor: DE KRETSER DAVID MORRITZ
IPC: C07K16/26
Filed: 1989-05-31
Abstract: PCT No. PCT/AU89/00245 Sec. 371 Date Apr. 2, 1990 Sec. 102(e) Date Apr. 2, 1990 PCT Filed May 31, 1989 PCT Pub. No. WO89/11862 PCT Pub. Date Dec. 14, 1989.The invention relates to novel uses for inhibin, inhibin  alpha  subunit, activin inhibin or activin antagonists and compositions comprising them in the treatment or prevention of immune dysfunction and blood clotting disorders. Methods of treatment include administration of the required agent to a host, immunization of the host with the agent or passive immunization using antibodies raised against one of these agents.
Patent EP-0419548-A1 (EP)
Title: Implant and method of making it.
Inventor: BRUCE LARS
IPC: A61L27/00
Filed: 1989-06-13
Abstract: An implant (prosthesis) comprises biological material in its surface intended to face the body tissue. The surface is formed of a layer (3) consisting of a mixture of grains (5) of tissue-compatible type and disintegrated tissue-compatible biological material (4). In a method of making the implant, an implant body (2) and a mixture of grains (5) of tissue-compatible type and disintegrated tissue-compatible biological material (4) as well as a nutrient solution (6) for the latter are placed in a mould (8). The biological material is allowed to grow in the mould, both out to the boundary wall of the mould cavity and in to the implant body.